Join the club for FREE to access the whole archive and other member benefits.
Key points from article :
CellAge is going to develop synthetic promoters which are specific to senescent cells, as promoters that are currently being used to track senescent cells are simply not good enough to be used in therapies.
Can you join me in donating to this Lifespan.io crowdfunding campaign?
Click on resource name for more details.
working with the aim to develop synthetic promoters that would be able to specifically identify senescent cells
Postdoctoral researcher working on synthetic biology, gene therapy and ageing and CEO & Co-Founder of CellAge.
Company that develops and commercializes synthetic promoters to control gene expressions and regulations
